Barclays
IART icon

Barclays’s Integra LifeSciences IART Stock Holding History

Barclays’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-245,100
Closed -$16.8M – 4404
2021
Q3 		$16.8M Buy
+245,100
New +$17.3M 0.01% 959
2021
Q2 		– Sell
-165,400
Closed -$11.4M – 4951
2021
Q1 		$11.4M Buy
+165,400
New +$11.2M 0.01% 1030
2017
Q1 		– Sell
-2,200
Closed -$94K – 6847
2016
Q4 		$94K Buy
+2,200
New +$89.4K ﹤0.01% 4793

Other funds holding IART

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return
Access Investment Management
Access Investment Management Atlanta, Georgia $412M AUM 14.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Leeward Investments
Leeward Investments Boston, Massachusetts $1.98B AUM 28.98% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Public Sector Pension Investment Board (PSP Investments)
Public Sector Pension Investment Board (PSP Investments) Montreal, Quebec, Canada $45.4B AUM 34.02% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

Barclays's IART Position: Q3 2026 in Review

Barclays increased its Integra LifeSciences (IART) stake by 615% in Q3 2026, buying an estimated $1.87M and bringing the position to 126,114 shares worth $2.05M. The position accounts for ﹤0.01% of the portfolio, ranked #2571.

Barclays first reported a position in IART in Q2 2013 and has held it in 53 quarters since. The position peaked at $6.07M in Q4 2022. 115 funds tracked by Wall St. Rank hold IART as of Q3 2026.

  • Barclays held 126,114 shares of Integra LifeSciences worth $2.05M as of Q3 2026.
  • Barclays bought 108,467 Integra LifeSciences shares in Q3 2026, an estimated $1.87M.
  • Integra LifeSciences made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #2571 holding.
  • Barclays first reported a position in Integra LifeSciences in Q2 2013 and has held it in 53 quarters since.
  • Barclays's Integra LifeSciences position peaked at $6.07M in Q4 2022.
  • 115 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.